), is providing some color on the stock. “We are maintaining our Overweight rating on CME. CME has underperformed in 2011,” J.P. Morgan writes. “With the outlook for Fed tightening quickly moving to mid-2012, owners of CME on an interest rate thesis have fled the stock. “We note that the interest rate outlook changes periodically and the growth concerns of today can easily become the inflation scares of tomorrow. For those who can hold through the summer, this represents a reasonably good tactical entry point.” CME Group closed Thursday at $266.25.